Women with borderline personality disorder may be at greater risk of perimenstrual worsening of emotional symptoms, with secondary worsening in the midluteal and follicular phases, as reported in a recent study.
Age, weight, oral corticosteroid use and strenuous exercise at age 18 years appear to be useful in predicting the 5-year risk of height loss of at least 1 inch in postmenopausal women, according to a study.
In women who have undergone hysterectomy and use hormone therapy, the risk of invasive breast cancer does not differ significantly when directly comparing different doses, formulations and routes of delivery, according to a study.
Women who continue treatment with olanzapine or quetiapine during pregnancy are at increased risk of gestational diabetes compared with those who discontinue use of these atypical antipsychotic medications prior to pregnancy, according to a study. The metabolic effects associated with the two drugs drive such risk.
Women who receive abortions appear to be significantly more likely to use antidepressants, although this pattern of use has less to do with the termination of pregnancy than with other risk factors for depression, according to a recent study.
Neurodevelopmental impairment (NDI) is common among preterm very-low birth weight (PT/VLBW) infants, according to a recent Singapore study, which additionally reports that the male sex and lack of antenatal steroids (ANS) are risk factors for delayed cognitive skills.
A high incidence of pruritus was found among parturients (ie, women about to give birth) following the administration of intrathecal morphine during spinal anaesthesia for Caesarean section (CS), according to a Singapore study.